Synonym
ME-3221; ME3221; ME 3221.
IUPAC/Chemical Name
3-Methoxy-2,6-dimethyl-4-(2'-(1H-tetrazol-5-yl) biphenyl-4-ylmethoxy)pyridine
InChi Key
FTDRSCZZEUAAIP-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H21N5O2/c1-14-12-20(21(28-3)15(2)23-14)29-13-16-8-10-17(11-9-16)18-6-4-5-7-19(18)22-24-26-27-25-22/h4-12H,13H2,1-3H3,(H,24,25,26,27)
SMILES Code
CC1=CC(OCC2=CC=C(C3=CC=CC=C3C4=NN=NN4)C=C2)=C(OC)C(C)=N1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
387.44
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Kawano K, Fujishima K, Nagura J, Yasuda S, Shinki, Hachisu M, Konno F. Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors. Eur J Pharmacol. 1998 Sep 11;357(1):33-9. PubMed PMID: 9788771.
2: Nagura J, Hui C, Yamamoto M, Yasuda S, Abe M, Hachisu M, Konno F. ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats. Jpn J Pharmacol. 1996 May;71(1):39-49. PubMed PMID: 8791170.
3: Nagura J, Yamamoto M, Hui C, Yasuda S, Hachisu M, Konno F. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1996 Mar;23(3):229-35. PubMed PMID: 8934613.
4: Nagura J, Yasuda S, Fujishima K, Yamamoto M, Hui C, Kawano K, Katano K, Ogino H, Hachisu M, Konno F. Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist. Eur J Pharmacol. 1995 Feb 14;274(1-3):201-11. PubMed PMID: 7768273.
5: Nagura J, Hui C, Yamamoto M, Yasuda S, Abe M, Hachisu M, Konno F. Effect of chronic treatment with ME3221 on blood pressure and mortality in aged stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S363-5. PubMed PMID: 9072429.